{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:24Z","timestamp":1786120344648,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/hjh.0b013e32834f6b43","type":"journal-article","created":{"date-parts":[[2012,1,21]],"date-time":"2012-01-21T07:17:17Z","timestamp":1327130237000},"page":"561-566","source":"Crossref","is-referenced-by-count":21,"title":["Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin\u2013angiotensin system activity in obese hypertensive patients"],"prefix":"10.1097","volume":"30","author":[{"given":"Michael","family":"Boschmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrg","family":"Nussberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Engeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H. Jan","family":"Danser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Ming","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret F.","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Dahlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210208","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2165\/00003495-200767120-00008","article-title":"Aliskiren: a review of its use in the management of hypertension.","volume":"67","author":"Frampton","year":"2007","journal-title":"Drugs"},{"key":"R2-21-20210208","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/HYPERTENSIONAHA.107.108845","article-title":"Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats.","volume":"52","author":"Feldman","year":"2008","journal-title":"Hypertension"},{"key":"R3-21-20210208","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-008-0329-z","article-title":"Direct renin inhibition: clinical pharmacology.","volume":"86","author":"Azizi","year":"2008","journal-title":"J Mol Med (Berl)"},{"key":"R4-21-20210208","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.108.123042","article-title":"Aliskiren accumulates in renin secretory granules and binds plasma prorenin.","volume":"52","author":"Krop","year":"2008","journal-title":"Hypertension"},{"key":"R5-21-20210208","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2006.11.032","article-title":"Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-h blood pressure control in patients with hypertension.","volume":"49","author":"Oh","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R6-21-20210208","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/jhh.2009.38","article-title":"Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study.","volume":"24","author":"Palatini","year":"2010","journal-title":"J Hum Hypertens"},{"key":"R7-21-20210208","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","article-title":"Weight loss and the renin-angiotensin-aldosterone system.","volume":"45","author":"Engeli","year":"2005","journal-title":"Hypertension"},{"key":"R8-21-20210208","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1210\/en.2008-0070","article-title":"Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat.","volume":"149","author":"Habibi","year":"2008","journal-title":"Endocrinology"},{"key":"R9-21-20210208","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1210\/en.2008-1391","article-title":"Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression.","volume":"150","author":"Lastra","year":"2009","journal-title":"Endocrinology"},{"key":"R10-21-20210208","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/HYPERTENSIONAHA.106.084301","article-title":"Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.","volume":"49","author":"Jordan","year":"2007","journal-title":"Hypertension"},{"key":"R11-21-20210208","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/HJH.0b013e32832be593","article-title":"Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.","volume":"27","author":"Schmieder","year":"2009","journal-title":"J Hypertens"},{"key":"R12-21-20210208","first-page":"2803","article-title":"Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism.","volume":"86","author":"Jordan","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-21-20210208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0160-5402(91)90021-V","article-title":"A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis.","volume":"25","author":"Stahle","year":"1991","journal-title":"J Pharmacol Methods"},{"key":"R14-21-20210208","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2337\/diabetes.52.4.942","article-title":"Association between adiponectin and mediators of inflammation in obese women.","volume":"52","author":"Engeli","year":"2003","journal-title":"Diabetes"},{"key":"R16-21-20210208","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00005344-198701000-00007","article-title":"Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.","volume":"9","author":"Nussberger","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"R17-21-20210208","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/HYPERTENSIONAHA.107.101287","article-title":"Interpretation of plasma renin concentration in patients receiving aliskiren therapy.","volume":"51","author":"Campbell","year":"2008","journal-title":"Hypertension"},{"key":"R18-21-20210208","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0006-291X(03)01451-7","article-title":"Structure-based design of aliskiren, a novel orally effective renin inhibitor.","volume":"308","author":"Wood","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R19-21-20210208","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/ki.2008.68","article-title":"Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes.","volume":"73","author":"Persson","year":"2008","journal-title":"Kidney Int"},{"key":"R20-21-20210208","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1097\/01.ASN.0000146686.35541.29","article-title":"Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.","volume":"15","author":"Azizi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R21-21-20210208","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2215\/CJN.00360107","article-title":"Hormonal and hemodynamic effects of aliskiren and valsartan and their combination in sodium-replete normotensive individuals.","volume":"2","author":"Azizi","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R22-21-20210208","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1161\/CIRCULATIONAHA.108.767202","article-title":"Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.","volume":"117","author":"Fisher","year":"2008","journal-title":"Circulation"},{"key":"R23-21-20210208","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/hy0102.102293","article-title":"Angiotensin II suppression in humans by the orally active renin inhibitor aliskiren (SPP100): comparison with enalapril.","volume":"39","author":"Nussberger","year":"2002","journal-title":"Hypertension"},{"key":"R24-21-20210208","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2337\/dc09-0168","article-title":"Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.","volume":"32","author":"Persson","year":"2009","journal-title":"Diabetes Care"},{"key":"R25-21-20210208","first-page":"803","article-title":"Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response J H","volume":"10","author":"van den Meiracker","year":"1992","journal-title":"ypertens"},{"key":"R26-21-20210208","first-page":"115","article-title":"Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension.","volume":"5","author":"Cappuccio","year":"1991","journal-title":"J Hum Hypertens"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-201203000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:33:49Z","timestamp":1786048429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-201203000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e32834f6b43","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}